Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.095 USD | -6.01% | -11.69% | -66.20% |
May. 21 | Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 14.05M |
---|---|---|---|---|---|
Net income 2022 | -42M | Net income 2023 | -48M | EV / Sales 2022 | - |
Net cash position 2022 | 51.14M | Net cash position 2023 | 14.58M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.5
x | P/E ratio 2023 |
-0.26
x | Employees | 22 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.69% |
1 day | -6.01% | ||
1 week | -11.69% | ||
Current month | -13.10% | ||
1 month | -20.65% | ||
3 months | -52.18% | ||
6 months | -66.20% | ||
Current year | -66.20% |
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 15-12-31 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-02 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 13-05-14 |
Timothy Block
BRD | Director/Board Member | 69 | 13-11-25 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 22-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 1.095 | -6.01% | 14,118 |
24-06-05 | 1.165 | -4.51% | 24,489 |
24-06-04 | 1.22 | +5.17% | 5,517 |
24-06-03 | 1.16 | -7.94% | 25,133 |
24-05-31 | 1.26 | +1.61% | 16,270 |
Delayed Quote Nasdaq, June 06, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-66.20% | 5.99M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.96% | 22.82B | |
-11.25% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- HEPA Stock